Adding a Lower Cutoff Value for CA19-9 May Identify Additional High-risk Cases of Pancreatic Cancer
Kathleen Medora / aacr - CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model for measuring the pancreatic tumor marker serum carbohydrate antigen 19-9 (CA19-9) identified patients with pancreatic canc…
AI Summary: Researchers propose lowering the CA19‑9 threshold to identify additional patients at high risk for pancreatic cancer. The analysis indicates the new cutoff improves detection of potentially dangerous cases without an unmanageable rise in false positives, offering a straightforward diagnostic tweak that could prompt earlier workups and treatment decisions.
Related Stories
Jeremy Clarkson treated for aggressive prostate cancer, now in remission / 21 days
Repeat PSMA PET scans change prostate cancer care for many patients / 2 days
Breast cancer incidence surges among Asian, Native Hawaiian, Pacific Islander women / 3 days
Early‑onset cancers rising; family history crucial for prevention / 25 days
Ultrasensitive HPV blood test detects head and neck recurrence months earlier / 4 wks
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 7 wks
UK records highest-ever skin cancer cases; severe cases rise / 7 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Pancreatic Cancer, Cybersecurity, Gene Therapy, Oncology and look for the RSS link.
StackHealth Time Machine